Borrelli, E., Coco, G., Scorcia, V., Carnevali, A., Reibaldi, M., Giannaccare, G. (2025). A Response to: Letter to the Editor Regarding “Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration”. OPHTHALMOLOGY AND THERAPY, 15(1), 499-501 [10.1007/s40123-025-01274-0].

A Response to: Letter to the Editor Regarding “Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration”

Coco, Giulia;
2025-12-03

3-dic-2025
Pubblicato
Rilevanza internazionale
Lettera
Esperti anonimi
Settore MEDS-17/A - Malattie dell'apparato visivo
English
Age-related macular degeneration;
Biomarkers;
Drusen;
Imaging;
Photobiomodulation
Borrelli, E., Coco, G., Scorcia, V., Carnevali, A., Reibaldi, M., Giannaccare, G. (2025). A Response to: Letter to the Editor Regarding “Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration”. OPHTHALMOLOGY AND THERAPY, 15(1), 499-501 [10.1007/s40123-025-01274-0].
Borrelli, E; Coco, G; Scorcia, V; Carnevali, A; Reibaldi, M; Giannaccare, G
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
unpaywall-bitstream-1214121177.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 174.16 kB
Formato Adobe PDF
174.16 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/459083
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact